In this randomized trial of women with confirmed preeclampsia, daily administration of 40 mg omeprazole did not significantly reduce the circulating levels of sFlt-1 and CT-proET-1, or increase the levels of PlGF after 4 or 8 days of treatment. This evidence concerns the gene PGF and preeclampsia.